Table 3.
Year
|
Organ/tissue
|
Approach
|
Animal model
|
Substitute implantation (cell type and scaffold/host anatomic site)
|
Cell concentration per scaffold
|
Outcomes
|
Ref.
|
2020 | Kidney | Diabetic nephropathy/unilateral nephrectomy | SDT fatty rats 5-week-old males, n = 21 | SC rat ASCs three-layer sheets/renal capsule transplantation | 1 × 106 cells in 35-mm culture dish/sheet | 14-d survival of transplanted sheets/significantly lower urinary TNF-α levels/maintained renal tubular structure in treated rats | Takemura et al[155], 2020 |
2018 | Kidney reconstruction | Wistar rats 6-8 week-old males | Inguinal rat ASCs seeded onto a rat decellularized kidney/no implantation | 1 × 107 cells in 2 ml of culture medium per decellularized kidney | ASCs differentiated into endothelial and tubular cells after 5 d of culture/few cells attached to the scaffold after 10 d | Xue et al[154], 2018 | |
2016 | Ureter | Artificial ureter injury/surgical excision | New Zealand white rabbits3.5 kg females, n = 20 | Smooth muscle like-cells from SC rabbit ASCs seeded onto ventral aorta/decellularized matrix/graft placed over ureter defect | N/S | Seeded ASCs showed urothelial and smooth muscle-like cells phenotype in the ureter substitute 8 wk after implantation | Zhao et al[165], 2016 |
2020 | Bladder | Complete bladder removal/surgical excision | SD rats 300 g adult females, n = 9 | SFP human ASCs seeded onto a decellularized rat bladder matrix/bladder transplantation | 1 × 106 cells in 500 μL of cells suspension/bladder scaffold | Acquisition of a smooth muscle-like phenotype of seeded ASCs seeded/ASC paracrine effect increased vascularization and innervation | Moreno-Manzano et al[163], 2020 |
2020 | Sub-totally resected urinary bladder/upper two-thirds bladder excision | Athymic rats 200 g adult females, n = 9 | Smooth muscle-like cells from SC human ASCs seeded onto 3-layer PLGA sheet/bladder graft anastomosis | 1 × 106 cells mixed with 500 μL of human plasma/scaffold | Complete bladder regeneration and functionality restoration/fusion of smooth muscle-like cells in the regenerated muscular layer | Salem et al[162], 2020 | |
2019 | Bladder injury/surgical incision(1 cm) | SD rats 6-week-old females, n = 48 | Inguinal rat ASCs cells and PGA combined sheets/bladder patch anastomose | 1 × 105 cells/cm2 per sheet reconstruction | Patches promote urothelium, smooth muscle, neural and blood vessel regeneration/restored bladder function | Wang et al[151], 2019 | |
2018 | Bladder augmentation/cystotomy incision (1 cm) | SD rats 8 week-old males, n = 34 | Inguinal rat ASCs seeded onto PCL-Chitosan scaffold/bladder substitute anastomose | 15 × 107 cells/mL per scaffold | Higher smooth-muscle regeneration from ASCs/larger bladder capacity/increased angiogenesis | Zhou et al[161], 2018 | |
2017 | Bladder augmentation/surgical incision(1 cm) | SD rats 8 week-old females, n = 46 | SC rat ASCs seeded onto an AM-SF scaffold/bladder substitute anastomose | 10 × 107 cells/mL in 40 μL of saline per scaffold | Bladder capacity augmentation (30%)/relatively normal micturition pattern/ASC viability after 12 wk of implantation | Wang et al[157], 2017 | |
2017 | Bladder augmentation/surgical incision (1 cm) | SD rats 8 week-old males, n = 30 | Inguinal rat ASCs seeded onto a BAMG-SF scaffold/bladder substitute anastomosis | 50 μL of cell suspension at 1 × 108 cells/mL per scaffold | Higher bladder capacity (2.3-fold)/Enhanced VEGF angiogenic potential by ERK ½ phosphorylation | Xiao et al[160], 2017 | |
2017 | Augmentation cystoplasty/surgical incision (1 cm) | SD rats 8 week-old males, n = 30 | Rat ASCs encapsulated in an ADA/GEL seeded onto a porcine BAMG/bladder substitute anastomosis | 100 μL of encapsulated cells at a 1 × 106/mL concentration per scaffold | Morphological bladder restoration by enhanced scaffold degradation/enhanced VEGF-mediated angiogenesis and smooth muscle regeneration in treated rats | Xiao et al[210], 2017 | |
2016 | Bladder augmentation/surgical incision (1 cm) | SD rats immunocompetent 36 week-old males, n = 30 | Inguinal rat ASCs seeded onto a porcine BAMG/Bladder substitute anastomosis | 15 × 107/mL cell suspension per scaffold | Greater bladder capacity in experimental group/equal urothelial regeneration in the treated and non-treated groups at 4- and 14-wk post-implantation | Zhe et al[156], 2016 | |
2016 | Partial cystectomy/half upper bladder transection | Beagle dogs 10-12 Kg males, n = 12 | Human ASCs seeded onto a whole porcine BAMG/scaffold grafted onto bladders’ dome | 1 × 105 cells per cm2 of each scaffold | Complete urothelial coverage of seeded and unseeded bladder after 6 mo/higher capillary density and smooth muscle organization in treated dogs’ bladder | Hou et al[159], 2016 | |
2020 | Urethra | Urethral injury/surgically induced | New Zealand white rabbits 9-week-old males, n = 24 | SC rabbit ASCs seeded onto a human DAM scaffold/urethral graft | 1 × 106 cells per scaffold | Higher number of urethras healed following seeding of ASCs onto DAM | Hariastawa et al[172], 2020 |
2020 | Urethral injury/surgically induced (2 cm × 0.6 cm) | New Zealand white rabbits males, n = 15 | Inguinal rabbit ASCs seeded in a nanofibrous scaffold/graft placed over urethral defect | 1 × 107 cells per scaffold | Hypoxia preconditioning of ASCs increased urethral lumen diameter/preserved morphology/enhanced angiogenesis | Wan et al[173], 2020 |
ADA-GEL: Alginate dialdehyde-gelatin; AM-SF: Autologous myofibroblast-silk fibroin; ASCs: Adipose-derived stromal/stem cells; BAMG-SF: Bladder acellular matrix graft-silk fibroin; bFGF: Basic fibroblast growth factor; DAM: Dried amniotic membrane; g: gram; Kg: Kilogram; N/S: Not specified PCL: Polycaprolactone; PGA: Polyglycolic acid; PLGA: Poly(lactid-co-glycolic acid); SC: Subcutaneous; SD: Sprague-Dawley; SDT: Spontaneously diabetic Torii; SFP: Suprapatellar fat pad; TNF-α: Tumor necrosis factor-α; VEGF: Vascular endothelial growth factor.